Divi's Laboratories Limited — Others, 03-02-2025: Change in Director(s)

Divi's Laboratories has announced a board meeting where it approved the financial results for the quarter and nine months ended December 31, 2024. The company reported a consolidated total income of ₹2401 crores, up from ₹1950 crores year-over-year, with a profit before tax of ₹726 crores, compared to ₹489 crores last year. Additionally, Dr. Kiran S. Divi has been re-appointed as the Whole-time Director and CEO for five years starting April 1, 2025, pending shareholder approval. With robust growth metrics and a strategic leadership move, investor sentiment may see a positive outlook.